231 related articles for article (PubMed ID: 16814578)
21. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
Lebensburger J; Persons DA
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
[TBL] [Abstract][Full Text] [Related]
22. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.
Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330
[TBL] [Abstract][Full Text] [Related]
23. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
24. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.
Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW
Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297
[TBL] [Abstract][Full Text] [Related]
25. Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells.
Moi P; Sadelain M
Haematologica; 2008 Mar; 93(3):325-30. PubMed ID: 18310536
[No Abstract] [Full Text] [Related]
26. Beta globin gene inhibition by antisense RNA transcripts.
Xu L; Ferry AE; Monteiro C; Pace BS
Gene Ther; 2000 Mar; 7(5):438-44. PubMed ID: 10694826
[TBL] [Abstract][Full Text] [Related]
27. Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia.
Sadelain M; Rivière I; Wang X; Boulad F; Prockop S; Giardina P; Maggio A; Galanello R; Locatelli F; Yannaki E
Ann N Y Acad Sci; 2010 Aug; 1202():52-8. PubMed ID: 20712772
[TBL] [Abstract][Full Text] [Related]
28. [A study of gene therapy for beta-thalassemia. I. Retroviral-mediated transfer of human beta-globin gene into Friend cells].
Shu H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Aug; 12(4):252-6. PubMed ID: 2147584
[TBL] [Abstract][Full Text] [Related]
29. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
Rivella S; May C; Chadburn A; Rivière I; Sadelain M
Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
[TBL] [Abstract][Full Text] [Related]
30. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
Sadelain M
Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924
[No Abstract] [Full Text] [Related]
31. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.
Fragkos M; Anagnou NP; Tubb J; Emery DW
Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728
[TBL] [Abstract][Full Text] [Related]
32. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
Bank A
Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
[TBL] [Abstract][Full Text] [Related]
33. Update on gene therapy for hemoglobin disorders.
Persons DA
Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
[TBL] [Abstract][Full Text] [Related]
34. Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
Perumbeti A; Malik P
Ann N Y Acad Sci; 2010 Aug; 1202():36-44. PubMed ID: 20712770
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy for homozygous beta-thalassemia. Is it a reality?
Boulad F; Rivière I; Sadelain M
Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
[TBL] [Abstract][Full Text] [Related]
36. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
37. Genetic therapy for beta-thalassemia: from the bench to the bedside.
Arumugam P; Malik P
Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833
[TBL] [Abstract][Full Text] [Related]
38. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
[TBL] [Abstract][Full Text] [Related]
39. [The possible mechanisms underlying low expression of human beta-globin gene cloned in a retroviral vector].
Dong WJ; Zu ZX; Liu DP; Hao DL; Guo ZC; Liang CC
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):763-8. PubMed ID: 12417921
[TBL] [Abstract][Full Text] [Related]
40. Lentivirus vectors in β-thalassemia.
Payen E; Colomb C; Negre O; Beuzard Y; Hehir K; Leboulch P
Methods Enzymol; 2012; 507():109-24. PubMed ID: 22365771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
